HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joachim Klosterkötter Selected Research

Prodromal Symptoms

1/2017Prevalence of metabolic syndrome in female and male patients at risk of psychosis.
12/2013Contributions of experimental psychiatry to research on the psychosis prodrome.
10/2011Prediction and prevention of schizophrenia: what has been achieved and where to go next?
6/2009Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophrenia.
5/2009Perceived negative attitude of others as an early sign of psychosis.
4/2009Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis.
8/2007CSF metabolic and proteomic profiles in patients prodromal for psychosis.
12/2006Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness.
8/2005Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment.
4/2004Early detection and secondary prevention of psychosis: facts and visions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joachim Klosterkötter Research Topics

Disease

23Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 04/2004
23Schizophrenia (Dementia Praecox)
01/2019 - 08/2003
10Prodromal Symptoms
01/2017 - 04/2004
4Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
01/2014 - 07/2003
4Mental Disorders (Mental Disorder)
10/2011 - 02/2004
3Dementia (Dementias)
12/2013 - 11/2004
3Paranoid Schizophrenia (Delusional Disorder)
06/2009 - 11/2004
2Anxiety Disorders (Anxiety Disorder)
07/2012 - 12/2003
2Bipolar Disorder (Manic Depressive Psychosis)
07/2012 - 06/2009
2Movement Disorders (Movement Disorder)
02/2010 - 07/2003
1Hallucinations (Hallucination)
01/2022
1Tourette Syndrome (Tourette's Syndrome)
03/2016
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
08/2014
1Panic Disorder (Panic Attack)
10/2012
1Psychomotor Agitation (Akathisia)
10/2012
1Depressive Disorder (Melancholia)
07/2012
1Alcoholism (Alcohol Abuse)
10/2011
1Sleep Deprivation
03/2009
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
07/2007
1Mood Disorders (Mood Disorder)
11/2004
1Parkinson Disease (Parkinson's Disease)
07/2003
1Essential Tremor (Essential Tremors)
07/2003

Drug/Important Bio-Agent (IBA)

15Antipsychotic Agents (Antipsychotics)IBA
01/2022 - 01/2004
5Biological ProductsIBA
12/2015 - 03/2008
5anandamide (arachidonylethanolamide)IBA
08/2014 - 11/2004
3oleoylethanolamideIBA
08/2014 - 03/2009
3Risperidone (Risperdal Consta)FDA LinkGeneric
02/2014 - 11/2008
3Haloperidol (Haldol)FDA LinkGeneric
02/2014 - 11/2008
3CannabinoidsIBA
03/2009 - 01/2004
2Pharmaceutical PreparationsIBA
01/2019 - 08/2007
2Fatty Acids (Saturated Fatty Acids)IBA
08/2014 - 03/2009
2EndocannabinoidsIBA
08/2014 - 04/2009
25-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
01/2014 - 06/2010
2NeuropeptidesIBA
10/2013 - 10/2012
22- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
06/2010 - 08/2003
2BenzodiazepinesIBA
07/2007 - 01/2004
2Amisulpride (Solian)IBA
08/2005 - 04/2004
1Acetylcysteine (Siran)FDA LinkGeneric
12/2019
1Antidepressive Agents (Antidepressants)IBA
07/2017
1Indicators and Reagents (Reagents)IBA
10/2016
1glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA
08/2014
1Hallucinogens (Psychedelics)IBA
12/2013
1gamma-Aminobutyric Acid (GABA)IBA
11/2012
1Propranolol (Inderal)FDA LinkGeneric
10/2012
1N-Methylaspartate (NMDA)IBA
10/2012
1Amino AcidsFDA Link
10/2012
1thiamine triphosphorate (TTP)IBA
07/2012
1Aripiprazole (Abilify)FDA Link
09/2011
1AcidsIBA
09/2011
1Serotonin ReceptorsIBA
06/2010
1Serotonin (5 Hydroxytryptamine)IBA
06/2010
1D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA
04/2010
1Neuroprotective AgentsIBA
09/2009
1Essential Fatty AcidsIBA
09/2009
1Cytochrome P-450 CYP2B1 (PROD)IBA
05/2009
1Biomarkers (Surrogate Marker)IBA
12/2008
1Protons (Proton)IBA
08/2007
1Glucose (Dextrose)FDA LinkGeneric
08/2007
1Proteins (Proteins, Gene)FDA Link
08/2007
1Lactic Acid (Lactate)FDA LinkGeneric
08/2007
1Peptides (Polypeptides)IBA
08/2007
1Prealbumin (Transthyretin)IBA
08/2007
1Neurotransmitter Agents (Neurotransmitter)IBA
08/2007
1Anticonvulsants (Antiepileptic Drugs)IBA
07/2007
1Dronabinol (THC)FDA LinkGeneric
12/2006
1AntibodiesIBA
02/2004
1Immunoglobulin G (IgG)IBA
02/2004

Therapy/Procedure

7Deep Brain Stimulation
03/2016 - 07/2003
6Therapeutics
01/2019 - 07/2003
2Secondary Prevention
03/2009 - 04/2004
1Electrodes (Electrode)
05/2011
1Telescopes
06/2009
1Ambulatory Care (Outpatient Care)
05/2009
1Lasers (Laser)
08/2007